You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 261 No. 7, February 17, 1989 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Concepts in Emergency and Critical Care
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (46)
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reperfusion Pulmonary Edema

Joseph M. Klausner, MD; Ian S. Paterson, MB, FRCS; John A. Mannick, MD; C. Robert Valeri, MD; David Shepro, PhD; Herbert B. Hechtman, MD

JAMA. 1989;261(7):1030-1035.


Abstract

Reperfusion following lower-torso ischemia in humans leads to respiratory failure manifest by pulmonary hypertension, hypoxemia, and noncardiogenic pulmonary edema. The mechanism of injury has been studied in the sheep lung lymph preparation, where it has been demonstrated that the reperfusion resulting in pulmonary edema is due to an increase in microvascular permeability of the lung to protein. This respiratory failure caused by reperfusion appears to be an inflammatory reaction associated with intravascular release of the chemoattractants leukotriene B4 and thromboxane. Histological studies of the lung in experimental animals revealed significant accumulation of neutrophils but not platelets in alveolar capillaries. We conclude that thromboxane generated and released from the ischemic tissue is responsible for the transient pulmonary hypertension. Second, it is likely that the chemoattractants are responsible for leukosequestration, and, third, neutrophils, oxygen-derived free radicals, and thromboxane moderate the altered lung permeability.

(JAMA 1989;261:1030-1035)



Author Affiliations

From the Department of Surgery, Brigham and Women's Hospital and Harvard Medical School, Boston (Drs Klausner, Paterson, Mannick, and Hechtman); the Naval Blood Research Laboratory, Boston University School of Medicine (Dr Valeri); and the Biological Science Center, Boston University (Dr Shepro).


Footnotes

Reprint requests to Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115 (Dr Hechtman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Comparative Effects of Intravenous Nicardipine and Prostaglandin E1 on the Cerebral Pial Arteriolar Constriction Seen After Unclamping of an Aortic Cross-Clamp in Rabbits
Kumazawa et al.
Anesth. Analg. 2007;104:659-665.
ABSTRACT | FULL TEXT  

{alpha}-Melanocyte-stimulating Hormone Inhibits Lung Injury after Renal Ischemia/Reperfusion
Deng et al.
Am. J. Respir. Crit. Care Med. 2004;169:749-756.
ABSTRACT | FULL TEXT  

Bypass Techniques for Descending Thoracic Aortic Surgery
Hessel
SEMIN CARDIOTHORAC VASC ANESTH 2001;5:293-320.
ABSTRACT  

Truth Is Stranger Than Fiction Department: The Surgeon, the Radiologist, the Authors, and JAMA Got it Right
Najarian
JAMA 1990;264:2076-2076.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1989 American Medical Association. All Rights Reserved.